 WAKEFIELD, Mass., April 07, 2021 GLOBE NEWSWIRE -- Innovation Pharmaceuticals OTCQB:IPIX the Company, a clinical stage biopharmaceutical company, today announced that antiviral data related to Brilacidin, the Companys defensin-mimetic drug candidate, has been accepted for an Oral Presentation at the American Society of Virologys 40th Annual Meeting ASV 2021, taking place July 19-23, 2021. 